PDGFRB and tarsal-carpal coalition syndrome: Based on those findings, it was suggested that PDGFR-β could play a role in canine TCC tumourigenesis and that PDGFR-β and VEGFR2 might be involved in mediating clinical response of TCC to toceranib but that this would be unlikely for c-KIT [90].